Inhibition of mTOR reduce Stat3 and PAI related angiogenesis in salivary gland adenoid cystic carcinoma

American Journal of Cancer Research

Volumn 4, Issue 6, 2014, Pages 764-775

  Yu, Guang Tao ^a   Bu, Lin Lin ^a   Zhao, Yu Yue ^a   Liu, Bing ^a   Zhang, Wen Feng ^a   Zhao, Yi Fang ^a   Zhang, Lu ^a   Sun, Zhi Jun ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Adenoid cystic carcinoma; Angiogenesis; mTOR; PAI; Rapamycin; Stat3

Indexed keywords

CD34 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; KI 67 ANTIGEN; MAMMALIAN TARGET OF RAPAMYCIN; PLASMINOGEN ACTIVATOR INHIBITOR; RAPAMYCIN; S6 KINASE; STAT3 PROTEIN;

ADENOID CYSTIC CARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; ENZYME ACTIVATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PLEOMORPHIC ADENOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SALIVARY GLAND CARCINOMA; SCORING SYSTEM; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; UPREGULATION;

EID: 84951746316     PISSN: None     EISSN: 21566976     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Dincer N, Tezel GG, Sungur A, Himmetoglu C, Huebner K and Guler G. Study of FHIT and WWOX expression in mucoepidermoid carcinoma and adenoid cystic carcinoma of salivary gland. Oral Oncol 2010; 46: 195-199.
2. Ellington CL, Goodman M, Kono SA, Grist W, Wadsworth T, Chen AY, Owonikoko T, Ramalingam S, Shin DM, Khuri FR, Beitler JJ and Saba NF. Adenoid cystic carcinoma of the head and neck: Incidence and survival trends based on 1973-2007 Surveillance, Epidemiology, and End Results data. Cancer 2012; 118: 4444-4451.
3. Ho AS, Kannan K, Roy DM, Morris LG, Ganly I, Katabi N, Ramaswami D, Walsh LA, Eng S, Huse JT, Zhang J, Dolgalev I, Huberman K, Heguy A, Viale A, Drobnjak M, Leversha MA, Rice CE, Singh B, Iyer NG, Leemans CR, Bloemena E, Ferris RL, Seethala RR, Gross BE, Liang Y, Sinha R, Peng L, Raphael BJ, Turcan S, Gong Y, Schultz N, Kim S, Chiosea S, Shah JP, Sander C, Lee W and Chan TA. The mutational landscape of adenoid cystic carcinoma. Nat Genet 2013; 45: 791-798.
4. Andry G, Hamoir M, Locati LD, Licitra L and Langendijk JA. Management of salivary gland tumors. Expert Rev Anticancer Ther 2012; 12: 1161-1168.
5. Wang YF, Zhang W, He KF, Liu B, Zhang L, Zhang WF, Kulkarni AB, Zhao YF and Sun ZJ. Induction of autophagy-dependent cell death by the survivin suppressant YM155 in salivary adenoid cystic carcinoma. Apoptosis 2014; 19: 748-758.
6. Chen G, Hu X, Zhang W, Xu N, Wang FQ, Jia J, Zhang WF, Sun ZJ and Zhao YF. Mammalian target of rapamycin regulates isoliquiritigenin-induced autophagic and apoptotic cell death in adenoid cystic carcinoma cells. Apoptosis 2012; 17: 90-101.
7. Sun ZJ, Chen G, Zhang W, Hu X, Liu Y, Zhou Q, Zhu LX and Zhao YF. Curcumin dually inhibits both mammalian target of rapamycin and nuInhibition of mTOR in AdCC clear factor-kappaB pathways through a crossed phosphatidylinositol 3-kinase/Akt/IkappaB kinase complex signaling axis in adenoid cystic carcinoma. Mol Pharmacol 2011; 79: 106-118.
8. Sun ZJ, Chen G, Zhang W, Hu X, Huang CF, Wang YF, Jia J and Zhao YF. Mammalian target of rapamycin pathway promotes tumor-induced angiogenesis in adenoid cystic carcinoma: its suppression by isoliquiritigenin through dual activation of c-Jun NH2-terminal kinase and inhibition of extracellular signal-regulated kinase. J Pharmacol Exp Ther 2010; 334: 500-512.
9. Sun ZJ, Chen G, Hu X, Zhang W, Liu Y, Zhu LX, Zhou Q and Zhao YF. Activation of PI3K/Akt/IKK-alpha/NF-kappaB signaling pathway is required for the apoptosis-evasion in human salivary adenoid cystic carcinoma: its inhibition by quercetin. Apoptosis 2010; 15: 850-863.
10. Molinolo AA, Amornphimoltham P, Squarize CH, Castilho RM, Patel V and Gutkind JS. Dysregulated molecular networks in head and neck carcinogenesis. Oral Oncol 2009; 45: 324-334.
11. Shin S, Wolgamott L, Roux PP and Yoon SO. Casein Kinase 1e promotes cell proliferation by regulating mRNA translation. Cancer Res 2014; 74: 201-11.
12. Schindler C and Darnell JE Jr. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 1995; 64: 621-651.
13. Darnell JE Jr. STATs and gene regulation. Science 1997; 277: 1630-1635.
14. Darnell JE Jr. Reflections on STAT3, STAT5, and STAT6 as fat STATs. Proc Natl Acad Sci U S A 1996; 93: 6221-6224.
15. Garcia R, Bowman TL, Niu G, Yu H, Minton S, Muro-Cacho CA, Cox CE, Falcone R, Fairclough R, Parsons S, Laudano A, Gazit A, Levitzki A, Kraker A and Jove R. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 2001; 20: 2499-2513.
16. Fernandes A, Hamburger AW and Gerwin BI. ErbB-2 kinase is required for constitutive stat 3 activation in malignant human lung epithelial cells. Int J Cancer 1999; 83: 564-570.
17. Kijima T, Niwa H, Steinman RA, Drenning SD, Gooding WE, Wentzel AL, Xi S and Grandis JR. STAT3 activation abrogates growth factor dependence and contributes to head and neck squamous cell carcinoma tumor growth in vivo. Cell Growth Differ 2002; 13: 355-362.
18. Sato K, Nagao T, Iwasaki T, Nishihira Y and Fukami Y. Src-dependent phosphorylation of the EGF receptor Tyr-845 mediates Stat-p21waf1 pathway in A431 cells. Genes Cells 2003; 8: 995-1003.
19. Vassalli JD, Sappino AP and Belin D. The plasminogen activator/plasmin system. J Clin Invest 1991; 88: 1067-1072.
20. Gomes-Giacoia E, Miyake M, Goodison S and Rosser CJ. Targeting plasminogen activator inhibitor-1 inhibits angiogenesis and tumor growth in a human cancer xenograft model. Mol Cancer Ther 2013; 12: 2697-2708.
21. Kimura H, Li X, Torii K, Okada T, Kamiyama K, Mikami D, Kasuno K, Takahashi N and Yoshida H. Glucocorticoid enhances hypoxia-and/or transforming growth factor-beta-induced plasminogen activator inhibitor-1 production in human proximal renal tubular cells. Clin Exp Nephrol 2011; 15: 34-40.
22. Ueno M, Maeno T, Nomura M, Aoyagi-Ikeda K, Matsui H, Hara K, Tanaka T, Iso T, Suga T and Kurabayashi M. Hypoxia-inducible factor-1alpha mediates TGF-beta-induced PAI-1 production in alveolar macrophages in pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2011; 300: L740-752.
23. Thompson L. World Health Organization classification of tumours: pathology and genetics of head and neck tumours. Ear Nose Throat J 2006; 85: 74.
24. Sun ZJ, Zhang L, Hall B, Bian Y, Gutkind JS and Kulkarni AB. Chemopreventive and chemotherapeutic actions of mTOR inhibitor in genetically defined head and neck squamous cell carcinoma mouse model. Clin Cancer Res 2012; 18: 5304-5313.
25. Eisen MB, Spellman PT, Brown PO and Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998; 95: 14863-14868.
26. de Araujo VC, Furuse C, Cury PR, Altemani A and de Araujo NS. STAT3 expression in salivary gland tumours. Oral Oncol 2008; 44: 439-445.
27. Huang Y, Yu T, Fu X, Chen J, Liu Y, Li C, Xia Y, Zhang Z and Li L. EGFR inhibition prevents in vitro tumor growth of salivary adenoid cystic carcinoma. BMC Cell Biol 2013; 14: 13.
28. Shirasuna K, Watatani K, Furusawa H, Saka M, Morioka S, Yoshioka H and Matsuya T. Biological characterization of pseudocyst-forming cell lines from human adenoid cystic carcinomas of minor salivary gland origin. Cancer Res 1990; 50: 4139-4145.
29. Shirasuna K, Saka M, Hayashido Y, Yoshioka H, Sugiura T and Matsuya T. Extracellular matrix production and degradation by adenoid cystic carcinoma cells: participation of plasminogen activator and its inhibitor in matrix degradation. Cancer Res 1993; 53: 147-152.
30. Lu P, Weaver VM and Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol 2012; 196: 395-406.
31. Jung SY, Song HS, Park SY, Chung SH and Kim YJ. Pyruvate promotes tumor angiogenesis through HIF-1-dependent PAI-1 expression. Int J Oncol 2011; 38: 571-576.
32. Dimova EY and Kietzmann T. The MAPK pathway and HIF-1 are involved in the induction of the human PAI-1 gene expression by insulin in the human hepatoma cell line HepG2. Ann N Y Acad Sci 2006; 1090: 355-367.
33. Barrett D, Brown VI, Grupp SA and Teachey DT. Targeting the PI3K/AKT/mTOR signaling axis in children with hematologic malignancies. Paediatr Drugs 2012; 14: 299-316.
34. Geng J, Li X, Lang X, Qiao C, Hu M, Yang J, Feng J and Lv M. Combination of Cetuximab and Rapamycin Enhances the Therapeutic Efficacy in Hepatocellular Carcinoma. Technol Cancer Res Treat 2013; 13: 377-85.
35. Ueno S, Sudo T, Oka N, Wakahashi S, Yamaguchi S, Fujiwara K, Mikami Y and Nishimura R. Absence of human papillomavirus infection and activation of PI3K-AKT pathway in cervical clear cell carcinoma. Int J Gynecol Cancer 2013; 23: 1084-1091.
36. Guilbert C, Annis MG, Dong Z, Siegel PM, Miller WH Jr. and Mann KK. Arsenic Trioxide Overcomes Rapamycin-Induced Feedback Activation of AKT and ERK Signaling to Enhance the Anti-Tumor Effects in Breast Cancer. PLoS One 2013; 8: e85995.
37. Alayev A, Sun Y, Snyder RB, Berger SM, Yu JJ and Holz MK. Resveratrol prevents rapamycin-induced upregulation of autophagy and selectively induces apoptosis in TSC2-deficient cells. Cell Cycle 2013; 13: 371-82.
38. Lu X, de la Pena L, Barker C, Camphausen K and Tofilon PJ. Radiation-induced changes in gene expression involve recruitment of existing messenger RNAs to and away from polysomes. Cancer Res 2006; 66: 1052-1061.
39. Kumaraswamy S, Chinnaiyan P, Shankavaram UT, Lu X, Camphausen K and Tofilon PJ. Radiation-induced gene translation profiles reveal tumor type and cancer-specific components. Cancer Res 2008; 68: 3819-3826.
40. Baumann M, Krause M and Hill R. Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer 2008; 8: 545-554.
41. Helbig L, Koi L, Bruchner K, Gurtner K, Hess-Stumpp H, Unterschemmann K, Pruschy M, Baumann M, Yaromina A and Zips D. Hypoxia-inducible factor pathway inhibition resolves tumor hypoxia and improves local tumor control after single-dose irradiation. Int J Radiat Oncol Biol Phys 2014; 88: 159-166.